Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures from...
Group Design02:01

Group Design

The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between the two are due to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcomes with emicizumab prophylaxis for haemophilia A in China: A multicentre, large-cohort retrospective study.

British journal of haematology·2026
Same author

Clinical efficacy of acupuncture in the treatment of sciatica during the remission phase of lumbar disc herniation: A secondary analysis of a randomized controlled trial.

Medicine·2026
Same author

Rapid start-up and nitrogen loading response of single-stage partial nitritation-anammox system using multi-channel internal circulation.

Bioresource technology·2026
Same author

Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG[PLUS]-CML 2023.

Cancer·2025
Same author

Rejuvenation mechanism of cross-linked epoxy resin on aged asphalt: insights from molecular dynamics and rheology.

Journal of molecular modeling·2025
Same author

Exploring potential mechanistic aspects of "Biaoben acupoint" acupuncture for lumbar disc herniation using 4D proteomics.

Frontiers in neurology·2025

Related Experiment Video

Updated: May 19, 2026

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills
06:52

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills

Published on: September 17, 2019

Varying Treatment Effects in Subgroups: A Unified Framework for Longitudinal Data Analysis.

Pu Zhang1, Xinsheng Zhang2, Jiao Jin1

  • 1School of Statistics, Beijing Normal University, Beijing, China.

Statistics in Medicine
|May 18, 2026
PubMed
Summary

This study introduces a new statistical model for analyzing how treatment effects change over time in specific patient subgroups using longitudinal data. The method identifies subgroups and their unique treatment responses without needing prior assumptions.

Keywords:
longitudinal datapenalized EM algorithmsubgroup analysisvarying coefficient model

More Related Videos

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Experiment Videos

Last Updated: May 19, 2026

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills
06:52

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills

Published on: September 17, 2019

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Area of Science:

  • Statistical modeling
  • Longitudinal data analysis
  • Precision medicine

Background:

  • Precision medicine necessitates analyzing subgroup-specific treatment effects.
  • Longitudinal data offers insights into evolving treatment effects over time.
  • Existing methods for subgroup-specific, time-varying effects are limited and rely on restrictive assumptions.

Purpose of the Study:

  • To propose a novel semiparametric subgroup-varying-coefficient model for longitudinal data.
  • To simultaneously estimate the number of subgroups and subgroup-specific time-varying treatment effects.
  • To overcome limitations of existing two-step procedures and restrictive assumptions.

Main Methods:

  • Developed a semiparametric subgroup-varying-coefficient model.
  • Utilized a penalized Expectation-Maximization (EM) algorithm for simultaneous subgroup identification and effect estimation.
  • Established theoretical properties including consistency and asymptotic normality of estimators.

Main Results:

  • The proposed method successfully identifies meaningful patient subgroups from longitudinal data.
  • Subgroup-specific, time-varying treatment effects were revealed.
  • Demonstrated efficacy and robustness through simulations and real-world data applications.

Conclusions:

  • The novel model effectively analyzes subgroup-specific, time-varying treatment effects in longitudinal data.
  • It avoids restrictive assumptions common in previous approaches.
  • The method holds promise for advancing precision medicine by uncovering nuanced treatment responses.